Opinicus Capital, Inc. Merck & Co., Inc. Transaction History
Opinicus Capital, Inc.
- $113 Billion
- Q1 2024
A detailed history of Opinicus Capital, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Opinicus Capital, Inc. holds 11,181 shares of MRK stock, worth $1.41 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
11,181
Previous 9,361
19.44%
Holding current value
$1.41 Million
Previous $1.02 Billion
44.55%
% of portfolio
1.31%
Previous 1.04%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,769Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.8 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.2 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.13 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $320B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...